Irene Vanni

1.5k total citations
45 papers, 920 citations indexed

About

Irene Vanni is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Irene Vanni has authored 45 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 18 papers in Molecular Biology and 16 papers in Cancer Research. Recurrent topics in Irene Vanni's work include Cancer Genomics and Diagnostics (12 papers), Lung Cancer Treatments and Mutations (12 papers) and Immunotherapy and Immune Responses (6 papers). Irene Vanni is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), Lung Cancer Treatments and Mutations (12 papers) and Immunotherapy and Immune Responses (6 papers). Irene Vanni collaborates with scholars based in Italy, United States and United Kingdom. Irene Vanni's co-authors include Francesco Grossi, Maria Giovanna Dal Bello, Simona Coco, Angela Alama, Carlo Genova, Federica Biello, Erika Rijavec, Giulia Barletta, Paola Ghiorzo and Francesco Spagnolo and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Irene Vanni

42 papers receiving 915 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irene Vanni Italy 16 456 390 323 319 137 45 920
Luciane T. Kagohara United States 15 576 1.3× 504 1.3× 286 0.9× 202 0.6× 253 1.8× 41 1.2k
Н. В. Литвяков Russia 18 417 0.9× 405 1.0× 270 0.8× 143 0.4× 154 1.1× 110 955
Laura Stanbery United States 17 557 1.2× 441 1.1× 242 0.7× 198 0.6× 273 2.0× 54 1.1k
Sandra Ortiz‐Cuaran France 16 527 1.2× 486 1.2× 297 0.9× 208 0.7× 151 1.1× 35 1.0k
Zhongyi Yan China 19 269 0.6× 729 1.9× 432 1.3× 246 0.8× 200 1.5× 43 1.1k
Christel van den Hoogen Netherlands 9 492 1.1× 542 1.4× 245 0.8× 164 0.5× 108 0.8× 9 930
Weiming Duan China 16 328 0.7× 406 1.0× 175 0.5× 151 0.5× 146 1.1× 39 819
Samuel J. Vidal United States 7 308 0.7× 473 1.2× 217 0.7× 164 0.5× 73 0.5× 12 798
Θεόδωρος Ράμπιας Greece 19 433 0.9× 691 1.8× 266 0.8× 199 0.6× 92 0.7× 46 1.2k
Meggy Suarez‐Carmona Belgium 16 624 1.4× 509 1.3× 331 1.0× 168 0.5× 396 2.9× 22 1.3k

Countries citing papers authored by Irene Vanni

Since Specialization
Citations

This map shows the geographic impact of Irene Vanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Vanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Vanni more than expected).

Fields of papers citing papers by Irene Vanni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irene Vanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Vanni. The network helps show where Irene Vanni may publish in the future.

Co-authorship network of co-authors of Irene Vanni

This figure shows the co-authorship network connecting the top 25 collaborators of Irene Vanni. A scholar is included among the top collaborators of Irene Vanni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irene Vanni. Irene Vanni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pastorino, Lorenza, Bruna Dalmasso, Irene Vanni, et al.. (2022). Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma. International Journal of Molecular Sciences. 23(24). 16027–16027. 4 indexed citations
2.
Izzotti, Alberto, Alessandra Pulliero, Simona Coco, et al.. (2021). Relationship between the miRNA Profiles and Oncogene Mutations in Non-Smoker Lung Cancer. Relevance for Lung Cancer Personalized Screenings and Treatments. Journal of Personalized Medicine. 11(3). 182–182. 9 indexed citations
3.
Genova, Carlo, Simona Coco, Giovanni Rossi, et al.. (2020). 1277P An exosomal miRNA signature as predictor of benefit from immune checkpoint inhibitors in non-small cell lung cancer. Annals of Oncology. 31. S825–S826. 2 indexed citations
4.
Vanni, Irene, Enrica T. Tanda, Bruna Dalmasso, et al.. (2020). Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications. Frontiers in Molecular Biosciences. 7. 172–172. 25 indexed citations
5.
Vanni, Irene, Enrica T. Tanda, Francesco Spagnolo, et al.. (2020). The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape. Frontiers in Molecular Biosciences. 7. 113–113. 43 indexed citations
6.
Genova, Carlo, Simona Boccardo, Marco Mora, et al.. (2019). Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab. Journal of Clinical Medicine. 8(10). 1566–1566. 23 indexed citations
7.
Coco, Simona, Silvia Bonfiglio, Davide Cittaro, et al.. (2019). Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer. Cancers. 11(4). 441–441. 3 indexed citations
8.
Bello, Maria Giovanna Dal, Rosangela Filiberti, Angela Alama, et al.. (2019). The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients. Journal of Translational Medicine. 17(1). 74–74. 124 indexed citations
9.
Dono, Mariella, Sonia Lastraioli, Maria Giovanna Dal Bello, et al.. (2019). Tag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patients. Molecular Medicine. 25(1). 15–15. 23 indexed citations
10.
Coco, Simona, Angela Alama, Irene Vanni, et al.. (2017). Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy. International Journal of Molecular Sciences. 18(5). 1035–1035. 37 indexed citations
11.
Vanni, Irene, Angela Alama, Francesco Grossi, Maria Giovanna Dal Bello, & Simona Coco. (2017). Exosomes: a new horizon in lung cancer. Drug Discovery Today. 22(6). 927–936. 89 indexed citations
12.
Genova, Carlo, Paolo Carrega, Gabriella Pietra, et al.. (2017). P3.02c-072 Predictive Immunologic Markers of Response to Nivolumab in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 12(1). S1320–S1321. 1 indexed citations
13.
Bello, Maria Giovanna Dal, Rosangela Filiberti, Carlo Genova, et al.. (2017). P2.01-067 The Relevance of CEA and CYFRA21-1 as Predictive Factors in Nivolumab Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients. Journal of Thoracic Oncology. 12(1). S827–S828. 3 indexed citations
14.
Bello, Maria Giovanna Dal, Angela Alama, Simona Coco, Irene Vanni, & Francesco Grossi. (2017). Understanding the checkpoint blockade in lung cancer immunotherapy. Drug Discovery Today. 22(8). 1266–1273. 42 indexed citations
15.
Ugolotti, Elisabetta, Patrizia Larghero, Irene Vanni, et al.. (2016). Whole-genome sequencing as standard practice for the analysis of clonality in outbreaks of meticillin-resistant Staphylococcus aureus in a paediatric setting. Journal of Hospital Infection. 93(4). 375–381. 14 indexed citations
16.
Bonfiglio, Silvia, Irene Vanni, Valeria Rossella, et al.. (2016). Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples. BMC Cancer. 16(1). 692–692. 21 indexed citations
17.
Vanni, Irene, Simona Coco, Anna Truini, et al.. (2015). Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform. International Journal of Molecular Sciences. 16(12). 28765–28782. 33 indexed citations
18.
Coco, Simona, Anna Truini, Irene Vanni, et al.. (2014). Next Generation Sequencing in Non-Small Cell Lung Cancer: New Avenues Toward the Personalized Medicine. Current Drug Targets. 16(1). 47–59. 38 indexed citations
19.
Truini, Anna, Angela Alama, Maria Giovanna Dal Bello, et al.. (2014). Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System. Frontiers in Oncology. 4. 242–242. 58 indexed citations
20.
Ugolotti, Elisabetta, et al.. (2011). Human leukocyte antigen–B (-Bw6/-Bw4 I80, T80) and human leukocyte antigen–C (-C1/-C2) subgrouping using pyrosequence analysis. Human Immunology. 72(10). 859–868. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luciane T. Kagohara Breakdown of academic impact, for papers by Н. В. Литвяков Breakdown of academic impact, for papers by Laura Stanbery Breakdown of academic impact, for papers by Sandra Ortiz‐Cuaran Breakdown of academic impact, for papers by Zhongyi Yan Breakdown of academic impact, for papers by Christel van den Hoogen Breakdown of academic impact, for papers by Weiming Duan Breakdown of academic impact, for papers by Samuel J. Vidal Breakdown of academic impact, for papers by Θεόδωρος Ράμπιας Breakdown of academic impact, for papers by Meggy Suarez‐Carmona
Rankless by CCL
2026